Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05241236 · ClinicalTrials.gov registry record
MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer
A clinical trial of Cancer of the Prostate and Neoplasms Prostate, sponsored by Urological Research Network.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT05241236: Recruiting study of Cancer of the Prostate and Neoplasms Prostate, sponsored by Urological Research Network.
NCT05241236 is a study of Cancer of the Prostate and Neoplasms Prostate that is actively recruiting participants, run by Urological Research Network. The registered enrollment target is 5,000 participants, above the 4,478-participant average among 11 other Cancer of the Prostate trials with a reported enrollment target (12% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05241236, a study of Cancer of the Prostate and Neoplasms Prostate, is actively recruiting participants, sponsored by Urological Research Network.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This serves as a registration trial. It aims to record short, intermediate, and long-term outcomes of patients treated with targeted laser ablation of biopsy confirmed prostate cancer. Outcomes will be categorized as: 1- Procedure Related, 2- Perioperative - Adverse Events that may occur within 90 days, 3-Oncologic: Recurrence of cancer in treatment area, de-novo tumors, conversion to radical surgery, radiation or cryoablation, emergence of metastasis, 4- Functional: Sexual and Urinary function following treatment
Primary Outcome
Negative CANCER Rate in treated area after fusion biopsy
Conditions Studied
Interventions
- DEVICE Image Fusion (MR/US) Software Registration Guided Laser Ablation of Prostate Cancer
Study Locations (1)
Florida
- Urological Research Network - Miami Lakes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2020-11-15 |
| Est. Completion | 2038-11 |
What NCT05241236 shows while recruiting
NCT05241236 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 4,478-participant average among 11 other Cancer of the Prostate trials with a reported enrollment target (12% higher).
The record links to 2 conditions, with Cancer of the Prostate appearing as the primary indexed condition, and to 1 intervention - of which Image Fusion (MR/US) Software Registration Guided Laser Ablation of Prostate Cancer is the first listed.
NCT05241236 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05241236 about?
NCT05241236 is a clinical study titled "MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer". This serves as a registration trial. It aims to record short, intermediate, and long-term outcomes of patients treated with targeted laser ablation of biopsy confirmed prostate cancer. Outcomes will be categorized as: 1- Procedure Related, 2- Perioperative - Adverse Events that may occur within 90 d...
What is the current status of trial NCT05241236?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2020-11-15. Estimated completion is 2038-11.
What conditions does trial NCT05241236 study?
This clinical trial studies the following conditions: Cancer of the Prostate, Neoplasms Prostate.
What interventions are being tested in trial NCT05241236?
The interventions under investigation include: Image Fusion (MR/US) Software Registration Guided Laser Ablation of Prostate Cancer (DEVICE).
Who is sponsoring clinical trial NCT05241236?
This trial is sponsored by Urological Research Network, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05241236 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer of the Prostate
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05241236's enrollment target sits among peer trials
5,000 2nd of 11 higher than 9 of 11 other Cancer of the Prostate trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer of the Prostate trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MRI/Ultrasound Fusion Guided Prostate Cryotherapy
RECRUITING
-
Investigation of Impact of AI on Prostate Cancer Workflow
RECRUITING · NA
-
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
RECRUITING · Phase 3
-
Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System
RECRUITING · NA
-
Proton Boost in Prostate Cancer
ACTIVE NOT RECRUITING · NA
-
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
ACTIVE NOT RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI